Nanoparticle delivery of innate immune agonists combined with senescence-inducing agents promotes T cell control of pancreatic cancer.

Published in:

Science Translational Medicine, 2024, v. 16, n. 762, p. 1, doi. 10.1126/scitranslmed.adj9366

By:

• Chibaya, Loretah;
• DeMarco, Kelly D.;
• Lusi, Christina F.;
• Kane, Griffin I.;
• Brassil, Meghan L.;
• Parikh, Chaitanya N.;
• Murphy, Katherine C.;
• Chowdhury, Shreya R.;
• Li, Junhui;
• Ma, Boyang;
• Naylor, Tiana E.;
• Cerrutti, Julia;
• Mori, Haruka;
• Diaz-Infante, Miranda;
• Peura, Jessica;
• Pitarresi, Jason R.;
• Zhu, Lihua Julie;
• Fitzgerald, Katherine A.;
• Atukorale, Prabhani U.;
• Ruscetti, Marcus

Publication type:

Article